TWI561238B - Inhibitor of the corneal epithelium cell death comprising flavin adenine dinucleotide or salts thereof as the an active ingredient - Google Patents

Inhibitor of the corneal epithelium cell death comprising flavin adenine dinucleotide or salts thereof as the an active ingredient

Info

Publication number
TWI561238B
TWI561238B TW101135280A TW101135280A TWI561238B TW I561238 B TWI561238 B TW I561238B TW 101135280 A TW101135280 A TW 101135280A TW 101135280 A TW101135280 A TW 101135280A TW I561238 B TWI561238 B TW I561238B
Authority
TW
Taiwan
Prior art keywords
inhibitor
salts
active ingredient
cell death
adenine dinucleotide
Prior art date
Application number
TW101135280A
Other languages
English (en)
Chinese (zh)
Other versions
TW201318628A (zh
Inventor
Asuka Sakamoto
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of TW201318628A publication Critical patent/TW201318628A/zh
Application granted granted Critical
Publication of TWI561238B publication Critical patent/TWI561238B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW101135280A 2011-09-27 2012-09-26 Inhibitor of the corneal epithelium cell death comprising flavin adenine dinucleotide or salts thereof as the an active ingredient TWI561238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011210875 2011-09-27

Publications (2)

Publication Number Publication Date
TW201318628A TW201318628A (zh) 2013-05-16
TWI561238B true TWI561238B (en) 2016-12-11

Family

ID=47995597

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101135280A TWI561238B (en) 2011-09-27 2012-09-26 Inhibitor of the corneal epithelium cell death comprising flavin adenine dinucleotide or salts thereof as the an active ingredient

Country Status (9)

Country Link
JP (1) JP5969872B2 (enExample)
KR (1) KR20140082699A (enExample)
CN (1) CN103826642B (enExample)
IN (1) IN2014DN03350A (enExample)
MY (1) MY185239A (enExample)
PH (1) PH12014500660A1 (enExample)
SG (2) SG10201602401PA (enExample)
TW (1) TWI561238B (enExample)
WO (1) WO2013047567A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016046734A2 (en) * 2014-09-22 2016-03-31 University Of The Western Cape Compounds and compositions for treatment of tuberculosis
EP4512395A1 (en) 2023-08-21 2025-02-26 Bio Even Composition comprising flavin adenine dinucleotide (fad), l-gsh, atp and myristic acid, alone or with a drug

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014080015A2 (en) * 2012-11-23 2014-05-30 Pilosciences Hair growth compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773076B1 (fr) * 1997-12-29 2000-05-19 Chauvin Lab Sa Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec
JP4836401B2 (ja) * 2002-04-01 2011-12-14 ロート製薬株式会社 眼科用組成物
JP2004203836A (ja) * 2002-12-26 2004-07-22 Rohto Pharmaceut Co Ltd 眼科用局所適用製剤
JP2005239622A (ja) * 2004-02-26 2005-09-08 Rohto Pharmaceut Co Ltd 角膜障害治療剤
JP4999304B2 (ja) * 2004-09-27 2012-08-15 ロート製薬株式会社 ヒアルロン酸又はその塩を含有する粘膜適用組成物
JP4969052B2 (ja) * 2005-03-31 2012-07-04 小林製薬株式会社 眼科用組成物
CN101301305A (zh) * 2008-05-14 2008-11-12 北京润德康医药技术有限公司 一种黄素腺嘌呤二核苷酸二钠冻干粉针制剂及其制备方法
JP5506357B2 (ja) * 2009-12-02 2014-05-28 ロート製薬株式会社 シリコーンハイドロゲルコンタクトレンズ用眼科組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014080015A2 (en) * 2012-11-23 2014-05-30 Pilosciences Hair growth compositions and methods

Also Published As

Publication number Publication date
KR20140082699A (ko) 2014-07-02
SG10201602401PA (en) 2016-04-28
IN2014DN03350A (enExample) 2015-06-05
TW201318628A (zh) 2013-05-16
CN103826642B (zh) 2016-02-17
JP2013082696A (ja) 2013-05-09
WO2013047567A1 (ja) 2013-04-04
SG11201400947XA (en) 2014-07-30
MY185239A (en) 2021-04-30
JP5969872B2 (ja) 2016-08-17
CN103826642A (zh) 2014-05-28
PH12014500660A1 (en) 2014-05-05

Similar Documents

Publication Publication Date Title
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
HUE043469T2 (hu) Hatóanyagként uracil-vegyületet tartalmazó herbicid kompozíció
DOP2014000152A (es) Inhibidores de bromodominios
MX2019003468A (es) Derivados de tieno [3,2-d]pirimidina que tienen actividad inhibidora de las cinasas de proteina.
EP2668184A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
EP2699266A4 (en) COMPOSITIONS AND METHODS FOR STABILIZING ACTIVE SUBSTANCES
IL237583A0 (en) Stable aqueous formulations of adlimumab
EP3064567A4 (en) Tool for vitrifying cryopreservation of cells or tissue
AP2012006539A0 (en) Use of formulations having insecticidal activity
EP2792693A4 (en) FLUORATED COPOLYMER AND WATER- / OIL-REPELLENT MEDIUM WITH THIS COPOLYMER AS AN ACTIVE SUBSTANCE
PT2766063T (pt) Cirurgia a laser da retina
EP2723345A4 (en) COMPOSITION WITH PHOSPHATIDYLCHOLIN AS AN ACTIVE AGENT TO REDUCE THE TOXICITY OF ANTICREMULATION
DK2931720T3 (da) Faststofdispersion med forbedret opløselighed omfattende tetrazolderivat som aktiv bestanddel
EP2749582A4 (en) FLUOROUS COPOLYMER AND SURFACE MODIFICATOR THEREFOR AS ACTIVE SUBSTANCE
ZA201306643B (en) Formulation comprising phenylaminopyrimidine derivatives as active agent
IL236466A0 (en) Pharmaceutical composition for the release of active components
EP2575842A4 (en) COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES
IL228462B (en) The film-forming composition for sustained release depends on the ph of an active ingredient
SG11201400947XA (en) Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient
SG11201400943RA (en) Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
PT2704698T (pt) Forma farmacêutica para a libertação controlada de princípios activos
GB2501050A (en) Pharmaceutical compositons of immunosuppressants
UY34279A (es) Compuestos heterocíclicos activos como microbiocidas, intermediarios, composiciones y usos
JP2013082696A5 (enExample)
EP3031462A4 (en) Medicine for preventing or suppressing survival of cancer cells and having organic acid polymer as active ingredient

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees